Alpha-1 Antitrypsin Deficiency Market The Alpha-1 Antitrypsin Deficiency market size in the 7MM was around USD 830 million in 2023 and is expected to increase with a significant CAGR during
Alpha-1 Antitrypsin Deficiency Market: Epidemiology, Therapies, Companies, DelveInsight | Arrowhead Pharmaceuticals, Mereo Biopharma, Kamada Ltd, Grifols, CSL Behring, Shire, LFB Biotechnologies
Inherited Retinal Disease Market To drive the Inherited Retinal Disease market in future years, several companies such as Endogena Therapeutics, Aldeyra Therapeutics, GenSight Biologics, and others are developing their assets
Tay-Sachs Disease Pipeline 2025 DelveInsight’s, “Tay-Sachs Disease – Pipeline Insight, 2025,” report provides comprehensive insights about 4+ companies and 5+ pipeline drugs in Tay-Sachs Disease pipeline landscape. It covers the
Metachromatic Leukodystrophy Pipeline 2025 DelveInsight’s, “Metachromatic Leukodystrophy – Pipeline Insight, 2025,” report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Metachromatic Leukodystrophy pipeline landscape. It covers the
GM1 Gangliosidosis Market GM1 Gangliosidosis is a rare lysosomal storage disorder with an incidence of 1 in 100,000–200,000 live births,
Vascular Closure Devices Market Global vascular closure devices market is expected to increase from USD 1,548.87 million in 2024 to
Non-Invasive Prenatal Testing Market The Down’s Syndrome Association stated that around one in every 1000 babies born in the United
Fanconi anemia Pipeline 2025 DelveInsight’s, “Fanconi Anemia (FA) – Pipeline Insight, 2025” report provides comprehensive insights about 3+ companies and
Primary Myelofibrosis Pipeline 2025 DelveInsight’s, “Primary myelofibrosis- Pipeline Insight, 2025” report provides comprehensive insights about 55+ companies and 55+ pipeline
Cardiac Amyloidosis Pipeline 2025 DelveInsight’s, “Cardiac Amyloidosis- Pipeline Insight, 2025,” report provides comprehensive insights about 20+ companies and 20+ pipeline
